Phosphorylation of Targeting Protein for Xenopus Kinesin-like Protein 2 (TPX2) at Threonine 72 in Spindle Assembly*

Background: The Targeting protein for Xenopus kinesin-like protein 2 (TPX2) is a key factor for spindle assembly; its deregulation is associated with numerous cancers. Results: Phosphorylation of TPX2 at Thr72 regulates its spindle assembly functions via Aurora A and Eg5. Conclusion: Proper regulation of TPX2 phosphorylation at Thr72 is required for spindle assembly. Significance: Our study provides new mechanistic insights into the spindle and cancers-associated roles of TPX2. The human ortholog of the targeting protein for Xenopus kinesin-like protein 2 (TPX2) is a cytoskeletal protein that plays a major role in spindle assembly and is required for mitosis. During spindle morphogenesis, TPX2 cooperates with Aurora A kinase and Eg5 kinesin to regulate microtubule organization. TPX2 displays over 40 putative phosphorylation sites identified from various high-throughput proteomic screenings. In this study, we characterize the phosphorylation of threonine 72 (Thr72) in human TPX2, a residue highly conserved across species. We find that Cdk1/2 phosphorylate TPX2 in vitro and in vivo. Using homemade antibodies specific for TPX2 phosphorylated at Thr72, we show that this phosphorylation is cell cycle-dependent and peaks at M phase. Endogenous TPX2 phosphorylated at Thr72 does not associate with the mitotic spindle. Furthermore, ectopic GFP-TPX2 T72A preferentially concentrates on the spindle, whereas GFP-TPX2 WT distributes to both spindle and cytosol. The T72A mutant also increases the proportion of cells with multipolar spindles phenotype. This effect is associated with increased Aurora A activity and abnormally elongated spindles, indicative of higher Eg5 activity. In summary, we propose that phosphorylation of Thr72 regulates TPX2 localization and impacts spindle assembly via Aurora A and Eg5.

[1]  I. Vernos,et al.  Non-centrosomal TPX2-Dependent Regulation of the Aurora A Kinase: Functional Implications for Healthy and Pathological Cell Division , 2016, Front. Oncol..

[2]  Gernot Neumayer,et al.  TPX2 Impacts Acetylation of Histone H4 at Lysine 16: Implications for DNA Damage Response , 2014, PloS one.

[3]  Gernot Neumayer,et al.  TPX2: of spindle assembly, DNA damage response, and cancer , 2014, Cellular and Molecular Life Sciences.

[4]  T. Mitchison,et al.  Branching Microtubule Nucleation in Xenopus Egg Extracts Mediated by Augmin and TPX2 , 2013, Cell.

[5]  Takeshi Tomonaga,et al.  Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. , 2013, Journal of proteome research.

[6]  M. Peng,et al.  Toward a comprehensive characterization of a human cancer cell phosphoproteome. , 2013, Journal of proteome research.

[7]  M. Malumbres,et al.  Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2. , 2012, Genes & cancer.

[8]  H. van Attikum,et al.  Targeting Protein for Xenopus Kinesin-like Protein 2 (TPX2) Regulates γ-Histone 2AX (γ-H2AX) Levels upon Ionizing Radiation* , 2012, The Journal of Biological Chemistry.

[9]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[10]  B. Maček,et al.  Global Detection of Protein Kinase D-dependent Phosphorylation Events in Nocodazole-treated Human Cells* , 2012, Molecular & Cellular Proteomics.

[11]  M. Malumbres,et al.  Tpx2 controls spindle integrity, genome stability, and tumor development. , 2012, Cancer research.

[12]  H. Daub,et al.  Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells. , 2012, Journal of proteomics.

[13]  Mark A van de Wiel,et al.  TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression , 2011, Gut.

[14]  Bin Zhang,et al.  PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse , 2011, Nucleic Acids Res..

[15]  P. Lavia,et al.  Aurora-A inactivation causes mitotic spindle pole fragmentation by unbalancing microtubule-generated forces , 2011, Molecular Cancer.

[16]  P. Wadsworth,et al.  TPX2 regulates the localization and activity of Eg5 in the mammalian mitotic spindle , 2011, The Journal of cell biology.

[17]  Otto Hudecz,et al.  Quantitative Phospho-proteomics to Investigate the Polo-like Kinase 1-Dependent Phospho-proteome* , 2011, Molecular & Cellular Proteomics.

[18]  Devin K Schweppe,et al.  Quantitative Phosphoproteomics Identifies Substrates and Functional Modules of Aurora and Polo-Like Kinase Activities in Mitotic Cells , 2011, Science Signaling.

[19]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[20]  P. Lavia,et al.  Control of Aurora-A stability through interaction with TPX2 , 2011, Journal of Cell Science.

[21]  Giulia Guarguaglini,et al.  The Aurora-A/TPX2 complex: a novel oncogenic holoenzyme? , 2010, Biochimica et biophysica acta.

[22]  D. Compton,et al.  Mechanisms of Chromosomal Instability , 2010, Current Biology.

[23]  S. Brunak,et al.  Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis , 2010, Science Signaling.

[24]  E. Nigg,et al.  Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages. , 2009, Journal of proteome research.

[25]  Jimmy K. Eng,et al.  Quantitative Phosphoproteomic Analysis of T Cell Receptor Signaling Reveals System-Wide Modulation of Protein-Protein Interactions , 2009, Science Signaling.

[26]  A. Lewellyn,et al.  Phosphorylation of TPX2 by Plx1 enhances activation of Aurora A , 2009, Cell cycle.

[27]  J. Yates,et al.  CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. , 2009, Cancer research.

[28]  Ruedi Aebersold,et al.  Identification of CDK2 substrates in human cell lysates , 2008, Genome Biology.

[29]  M. Mann,et al.  Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. , 2008, Molecular cell.

[30]  S. Elledge,et al.  A quantitative atlas of mitotic phosphorylation , 2008, Proceedings of the National Academy of Sciences.

[31]  Patrick A. Eyers,et al.  Spindle Pole Regulation by a Discrete Eg5-Interacting Domain in TPX2 , 2008, Current Biology.

[32]  R. Margolis,et al.  Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed , 2007, The Journal of cell biology.

[33]  K. Fukui,et al.  Nucleolin functions in nucleolus formation and chromosome congression , 2007, Journal of Cell Science.

[34]  Z. Szallasi,et al.  A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers , 2006, Nature Genetics.

[35]  Erich A Nigg,et al.  Phosphoproteome analysis of the human mitotic spindle. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Stewart,et al.  Anaphase-Promoting Complex/Cyclosome Controls the Stability of TPX2 during Mitotic Exit , 2005, Molecular and Cellular Biology.

[37]  R. Pepperkok,et al.  Characterization of the TPX2 domains involved in microtubule nucleation and spindle assembly in Xenopus egg extracts. , 2004, Molecular biology of the cell.

[38]  J. Maller,et al.  Regulation of Xenopus Aurora A Activation by TPX2* , 2004, Journal of Biological Chemistry.

[39]  A. Wilde,et al.  Ran modulates spindle assembly by regulating a subset of TPX2 and Kid activities including Aurora A activation , 2003, Journal of Cell Science.

[40]  Richard Bayliss,et al.  Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. , 2003, Molecular cell.

[41]  A. Hoenger,et al.  Importin α‐regulated nucleation of microtubules by TPX2 , 2003 .

[42]  T. Kapoor,et al.  hTPX2 Is Required for Normal Spindle Morphology and Centrosome Integrity during Vertebrate Cell Division , 2002, Current Biology.

[43]  R. Pepperkok,et al.  Chromosome-induced microtubule assembly mediated by TPX2 is required for spindle formation in HeLa cells , 2002, Nature Cell Biology.

[44]  Roman Körner,et al.  Human TPX2 is required for targeting Aurora-A kinase to the spindle , 2002, The Journal of cell biology.

[45]  J. Julien,et al.  Deregulation of Cdk5 in a Mouse Model of ALS Toxicity Alleviated by Perikaryal Neurofilament Inclusions , 2001, Neuron.

[46]  Timothy J. Mitchison,et al.  Probing Spindle Assembly Mechanisms with Monastrol, a Small Molecule Inhibitor of the Mitotic Kinesin, Eg5 , 2000, The Journal of cell biology.

[47]  Eric Karsenti,et al.  Tpx2, a Novel Xenopus Map Involved in Spindle Pole Organization , 2000, The Journal of cell biology.

[48]  D. N. Perkins,et al.  Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.

[49]  H. Pant,et al.  Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  I. Vernos,et al.  Localization of the Kinesin-like Protein Xklp2 to Spindle Poles Requires a Leucine Zipper, a Microtubule-associated Protein, and Dynein , 1998, The Journal of cell biology.

[51]  Brian Schryver,et al.  A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers , 1998, The EMBO journal.

[52]  R. Liem,et al.  Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. , 1998, Journal of neurobiology.

[53]  R. Parwaresch,et al.  p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M. , 1997, Blood.

[54]  L. Meijer,et al.  Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. , 1997, Journal of medicinal chemistry.

[55]  S H Kim,et al.  Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. , 1997, European journal of biochemistry.

[56]  L. Tsai,et al.  p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 , 1994, Nature.

[57]  J. Labbé,et al.  Mitosis-specific phosphorylation of nucleolin by p34cdc2 protein kinase , 1990, Molecular and cellular biology.

[58]  J. Labbé,et al.  Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase , 1990, Cell.

[59]  J. Sarkaria,et al.  Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma , 2016, Journal of Neuro-Oncology.

[60]  A. Venkitaraman,et al.  AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. , 2003, Cancer cell.

[61]  L Meijer,et al.  Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. , 1997, European journal of biochemistry.